First Quadrant’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-6,776
| Closed | -$77K | – | 684 |
|
|
2020
Q2 | $77K | Sell |
6,776
-13,580
| -67% | -$154K | 0.01% | 605 |
|
|
2020
Q1 | $291K | Buy |
+20,356
| New | +$291K | 0.04% | 354 |
|
|
2019
Q1 | – | Sell |
-4,441
| Closed | -$129K | – | 772 |
|
|
2018
Q4 | $129K | Buy |
4,441
+80
| +2% | +$2.32K | 0.01% | 609 |
|
|
2018
Q3 | $201K | Buy |
+4,361
| New | +$201K | ﹤0.01% | 624 |
|
|
2016
Q4 | – | Sell |
-36,564
| Closed | -$752K | – | 880 |
|
|
2016
Q3 | $752K | Buy |
+36,564
| New | +$752K | 0.02% | 481 |
|
|
2014
Q3 | – | Sell |
-272,700
| Closed | -$10.6M | – | 832 |
|
|
2014
Q2 | $10.6M | Sell |
272,700
-197,100
| -42% | -$7.67M | 0.24% | 128 |
|
|
2014
Q1 | $16.1M | Sell |
469,800
-143,700
| -23% | -$4.91M | 0.36% | 81 |
|
|
2013
Q4 | $12.9M | Buy |
613,500
+332,800
| +119% | +$6.98M | 0.3% | 102 |
|
|
2013
Q3 | $6.6M | Buy |
280,700
+193,900
| +223% | +$4.56M | 0.17% | 166 |
|
|
2013
Q2 | $2.33M | Buy |
+86,800
| New | +$2.33M | 0.06% | 271 |
|